Ingrid Kolfschoten

977 total citations
12 papers, 808 citations indexed

About

Ingrid Kolfschoten is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ingrid Kolfschoten has authored 12 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Ingrid Kolfschoten's work include RNA Interference and Gene Delivery (5 papers), Muscle Physiology and Disorders (3 papers) and MicroRNA in disease regulation (3 papers). Ingrid Kolfschoten is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Muscle Physiology and Disorders (3 papers) and MicroRNA in disease regulation (3 papers). Ingrid Kolfschoten collaborates with scholars based in Netherlands, Switzerland and Spain. Ingrid Kolfschoten's co-authors include Reuven Agami, Karine Lefort, Bart van Leeuwen, Jasper Mullenders, Roderick L. Beijersbergen, René Bernards, Paola Ostano, P. Mathijs Voorhoeve, Katrien Berns and G. Paolo Dotto and has published in prestigious journals such as Cell, Genes & Development and The EMBO Journal.

In The Last Decade

Ingrid Kolfschoten

12 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Kolfschoten Netherlands 9 587 205 188 90 72 12 808
Antonia Boyer United States 8 782 1.3× 150 0.7× 134 0.7× 40 0.4× 82 1.1× 14 1.0k
Shangda Yang China 12 785 1.3× 140 0.7× 265 1.4× 184 2.0× 80 1.1× 19 1.1k
Young Jin Gi United States 11 800 1.4× 338 1.6× 483 2.6× 176 2.0× 38 0.5× 18 1.1k
Silvia Pandolfi Italy 14 676 1.2× 140 0.7× 361 1.9× 39 0.4× 81 1.1× 19 870
Indira V. Subramanian United States 12 699 1.2× 483 2.4× 101 0.5× 202 2.2× 93 1.3× 15 1.0k
Qing‐Shuo Zhang United States 11 656 1.1× 96 0.5× 109 0.6× 30 0.3× 76 1.1× 20 804
Yizhou Huang China 14 637 1.1× 225 1.1× 117 0.6× 41 0.5× 36 0.5× 35 880
Cristian Papazoglu United States 6 572 1.0× 153 0.7× 345 1.8× 28 0.3× 81 1.1× 8 801
Marina Rocchigiani Italy 13 709 1.2× 87 0.4× 170 0.9× 67 0.7× 51 0.7× 26 887
Nadia J. Gavrilova Bulgaria 6 875 1.5× 156 0.8× 267 1.4× 30 0.3× 46 0.6× 10 1.0k

Countries citing papers authored by Ingrid Kolfschoten

Since Specialization
Citations

This map shows the geographic impact of Ingrid Kolfschoten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Kolfschoten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Kolfschoten more than expected).

Fields of papers citing papers by Ingrid Kolfschoten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Kolfschoten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Kolfschoten. The network helps show where Ingrid Kolfschoten may publish in the future.

Co-authorship network of co-authors of Ingrid Kolfschoten

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Kolfschoten. A scholar is included among the top collaborators of Ingrid Kolfschoten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Kolfschoten. Ingrid Kolfschoten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Roovers, Rob C., Bram Herpers, Mark I. James, et al.. (2017). Abstract 32: Preclinical evaluation of MCLA-158: A bispecific antibody targeting LGR5 and EGFR using patient-derived colon carcinoma organoids. Cancer Research. 77(13_Supplement). 32–32. 4 indexed citations
2.
Verhaart, Ingrid E.C., Jessica A. Sipkens, Sjef J. de Kimpe, et al.. (2014). The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice. Molecular Therapy — Nucleic Acids. 3. e148–e148. 25 indexed citations
3.
Lefort, Karine, Yang Brooks, Paola Ostano, et al.. (2013). A miR‐34a‐SIRT6 axis in the squamous cell differentiation network. The EMBO Journal. 32(16). 2248–2263. 112 indexed citations
4.
Verhaart, Ingrid E.C., et al.. (2013). Dose-Dependent Pharmacokinetic Profiles of 2′- O -Methyl Phosphorothioate Antisense Oligonucleotidesin mdx Mice. Nucleic Acid Therapeutics. 23(3). 228–237. 20 indexed citations
5.
Verhaart, Ingrid E.C., Hans Heemskerk, Ingrid Kolfschoten, et al.. (2011). Prednisolone Treatment Does Not Interfere with 2′- O -Methyl Phosphorothioate Antisense-Mediated Exon Skipping in Duchenne Muscular Dystrophy. Human Gene Therapy. 23(3). 262–273. 14 indexed citations
6.
Kolfschoten, Ingrid, E. Roggli, Valeria Nesca, & Romano Regazzi. (2009). Role and therapeutic potential of microRNAs in diabetes. Diabetes Obesity and Metabolism. 11(s4). 118–129. 51 indexed citations
7.
Lefort, Karine, Anna Mandinova, Paola Ostano, et al.. (2007). Notch1 is a p53 target gene involved in human keratinocyte tumor suppression through negative regulation of ROCK1/2 and MRCKα kinases. Genes & Development. 21(5). 562–577. 258 indexed citations
8.
Kolfschoten, Ingrid & Romano Regazzi. (2007). Technology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases. Nature Clinical Practice Endocrinology & Metabolism. 3(12). 827–834. 6 indexed citations
9.
Kolfschoten, Ingrid, Bart van Leeuwen, Katrien Berns, et al.. (2005). A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and Tumorigenicity. Cell. 121(6). 849–858. 220 indexed citations
10.
Gagrica, Sladjana, Stefanie Hauser, Ingrid Kolfschoten, et al.. (2004). Inhibition of oncogenic transformation by mammalian Lin‐9, a pRB‐associated protein. The EMBO Journal. 23(23). 4627–4638. 52 indexed citations
11.
Bots, Michael, Ingrid Kolfschoten, Mirjam Rademaker, et al.. (2004). SPI-CI and SPI-6 cooperate in the protection from effector cell–mediated cytotoxicity. Blood. 105(3). 1153–1161. 45 indexed citations
12.
Kolfschoten, Ingrid & Reuven Agami. (2003). RNA interference gene therapy: Allelic gene inactivation: pinpointing the problem. Gene Therapy. 10(23). 1931–1932. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonia Boyer Breakdown of academic impact, for papers by Shangda Yang Breakdown of academic impact, for papers by Young Jin Gi Breakdown of academic impact, for papers by Silvia Pandolfi Breakdown of academic impact, for papers by Indira V. Subramanian Breakdown of academic impact, for papers by Qing‐Shuo Zhang Breakdown of academic impact, for papers by Yizhou Huang Breakdown of academic impact, for papers by Cristian Papazoglu Breakdown of academic impact, for papers by Marina Rocchigiani Breakdown of academic impact, for papers by Nadia J. Gavrilova
Rankless by CCL
2026